Login & Signup

  • PreIPO
  • Startup Fund Raising
  • Valuations
  • Equity Restructing

  • Investments
  • Mutual Funds
  • Demat Account
  • Bonds/NCD
  • Insurance
  • Life Insurance
  • Health Insurance
  • Car Insurance
  • Corporates & Business
  • Property Insurance
  • Group Health Insurance
  • Marine Insurance

F
Snapshot
Key Ratio
Peers
Financials
Ownership
News
Events

RATING

RECOMMENDATION

Neutral

  • Portfolio

  • Basket

  • Watchlist

  • More

Snapshot
Key Ratio
Peers
Financials
Ownership
News
Events

RATING

RECOMMENDATION

Neutral

Business Type

Near Leader

Here are the Balance Sheet Statement and other details about the all Financial Results of Sigachi Laboratories Limited ending on 31st March 2021. Actual numbers and more financial data including Total Assets, Total Shareholders fund, and all the annual reports of the company. Also, get to know the Sigachi Laboratories Share Price.

Sigachi Laboratories Balance Sheet

  • Total Assets

    The total asset of the company has increased by 3.5% at CAGR in 3 years from FY17 to FY20.

  • Inventory

    The company works on a zero inventory model.

  • Total Debt

    The company is a debt-free company.

Financial Year
Cash & Short Term Investments
Total Receivables
Total Inventory
Prepaid Expenses
Current Investments
Other Current Financial Assets
Loan & Advances
Deferred Tax Assest
Current Assets
Net Property/Plant/Equipment
Goodwill
Other Intangible Assets
Intangible Assets Under Development
Long Term Investments
Deferred Tax Assets (Net)
Other Non Current Assets
Non Current Assets
Total Assets
Accounts Payable
Total Deposits
Current Portion of Long Term Debt
Unearned Revenue
Current Portion of Leases
Other Current Liabilities
Current Liabilities
Total Long Term Debt
Long Term Portion of Leases
Deferred Tax Liabilities (Net)
Other Non Current Liabilities
Non Current Liablities
Total Liabilities
Common Stock
Other Equity
Reserves & Surplus
Additional Paid-in Capital
Retained Earnings
Minority Interest
Treasure Stock
Comprehensive Inc. & Other
Total Equity
Total Common Shares Outstanding
Total Liabilities & Shareholder's Equity
FY 2017

30.47

9.02

-

-

437.09

66.86

-

-

543.44

267.41

-

-

-

961.86

-

73.66

1,302.93

1,846.38

8.01

-

-

-

-

4.3

12.31

-

-

16.47

22.92

39.39

51.69

731.06

1,063.63

-

-

-

-

-

-

1,794.68

731.06

1,846.38

FY 2018

19.6

9.18

-

-

492.66

65.34

-

-

586.77

306.14

-

-

-

1,084.22

-

72.25

1,462.61

2,049.38

-

-

-

-

-

5.31

5.31

-

-

16.26

47.02

63.28

68.59

731.06

1,249.73

-

-

-

-

-

-

1,980.79

731.06

2,049.38

FY 2019

202.88

14.68

-

-

20.42

65

-

-

302.98

271.49

-

-

-

1,584.27

-

69.65

1,925.4

2,228.38

-

-

-

-

-

54.3

54.3

-

-

8.52

26.02

34.54

88.83

731.06

1,408.49

-

-

-

-

-

-

2,139.54

731.06

2,228.38

FY 2020

210.17

20.85

-

-

21.26

248.35

-

-

500.62

261.65

-

-

-

1,239.05

-

43.53

1,544.23

2,044.85

-

-

-

-

-

11.18

11.18

-

-

19.31

26.96

46.28

57.46

731.06

1,256.34

-

-

-

-

-

-

1,987.39

731.06

2,044.85

Shares outstanding numbers in L. Other numbers in ₹ L

* denotes current year's data

  • Sigachi Laboratories Annual Reports

2017

Annual Report

2018

Annual report

2020

Annual Report

  • ROFR Required

Available in Depository

  • NSDL

  • CDSL

Available for Investment

  • Primary

  • Secondary

  • Investment Checklist

Management

Accounting Practice

Profitability

Solvency

Growth

Valuation